Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (391-400 of 682) with videos related to

Pageof 69
Sort By:
The Journal of Antimicrobial Chemotherapy|June 9, 2022
Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?Yarmarly C Guerra Valero, Tavey Dorofaeff, Mark G Coulthard, et al.
Analytical and Bioanalytical Chemistry|May 27, 2021
Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill childrenYarmarly C Guerra Valero, Tavey Dorofaeff, Jason A Roberts, et al.
Bioanalysis|March 17, 2023
Quantification of levetiracetam in plasma and urine and its application to a pharmacokinetic study of traumatic brain injury patientsSantosh Ks Adiraju, Chandra D Sumi, Saurabh Pandey, et al.
International Journal of Antimicrobial Agents|July 8, 2019
Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltrationCaleb J P Economou, Jiao Xie, Gregory Comadira, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2019
Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize <i>A Priori</i> Pharmacokinetic/Pharmacodynamic Target Attainments in Individual PatientsClément Boidin, Laurent Bourguignon, Sabine Cohen, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2018
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic modelsSofie A M Dhaese, Andras Farkas, Pieter Colin, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2012
Characterization of poliovirus variants selected for resistance to the antiviral compound V-073Hong-Mei Liu, Jason A Roberts, Deborah Moore, et al.
Einstein (Sao Paulo, Brazil)|January 30, 2020
Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment softwareSamuel Dutra da Silva, Geisa Cristina da Silva Alves, Farah Maria Drumond Chequer, et al.
International Journal of Antimicrobial Agents|December 3, 2014
Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administrationJanattul-Ain Jamal, Mohd-Basri Mat-Nor, Fariz-Safhan Mohamad-Nor, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 3, 2022
Pharmacokinetics of valganciclovir and voriconazole during prolonged intermittent renal replacement therapy in a lung transplant recipientTimothy J Whitmore, Vesa Cheng, Matthew D Rawlins, et al.
Pageof 69

Showing results (391-400 of 682) with videos related to

Sort By:
Pageof 69
The Journal of Antimicrobial Chemotherapy|June 9, 2022
Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?Yarmarly C Guerra Valero, Tavey Dorofaeff, Mark G Coulthard, et al.
Analytical and Bioanalytical Chemistry|May 27, 2021
Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill childrenYarmarly C Guerra Valero, Tavey Dorofaeff, Jason A Roberts, et al.
Bioanalysis|March 17, 2023
Quantification of levetiracetam in plasma and urine and its application to a pharmacokinetic study of traumatic brain injury patientsSantosh Ks Adiraju, Chandra D Sumi, Saurabh Pandey, et al.
International Journal of Antimicrobial Agents|July 8, 2019
Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltrationCaleb J P Economou, Jiao Xie, Gregory Comadira, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2019
Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize <i>A Priori</i> Pharmacokinetic/Pharmacodynamic Target Attainments in Individual PatientsClément Boidin, Laurent Bourguignon, Sabine Cohen, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2018
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic modelsSofie A M Dhaese, Andras Farkas, Pieter Colin, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2012
Characterization of poliovirus variants selected for resistance to the antiviral compound V-073Hong-Mei Liu, Jason A Roberts, Deborah Moore, et al.
Einstein (Sao Paulo, Brazil)|January 30, 2020
Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment softwareSamuel Dutra da Silva, Geisa Cristina da Silva Alves, Farah Maria Drumond Chequer, et al.
International Journal of Antimicrobial Agents|December 3, 2014
Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administrationJanattul-Ain Jamal, Mohd-Basri Mat-Nor, Fariz-Safhan Mohamad-Nor, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 3, 2022
Pharmacokinetics of valganciclovir and voriconazole during prolonged intermittent renal replacement therapy in a lung transplant recipientTimothy J Whitmore, Vesa Cheng, Matthew D Rawlins, et al.
Pageof 69